spracticeХирургическая практикаSurgical practice (Russia)2223-2427АНО "Консорциум "Медицинская техника"spractice-25Research ArticleMANU PROPRIA. ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯМЕСТО ТРАНСУРЕТРАЛЬНОЙ РЕЗЕКЦИИ В ДИАГНОСТИКЕ РАКА ПРЕДСТАТЕЛЬНОЙ ЖЕЛЕЗЫЗимичевАлександр АнатольевичZimichevA. A.Zimichew@mail.ruКорабельниковАлександр СергеевичKorabelnikovA. S.nihilius2009@rambler.ruЧернышевИгорь ВладиславовичChernyshevI. V.ivchernyshev@fgu-obp.ruНизамоваРумия СахабовнаNizamovaR. S.nizamovars@ya.ruГубановЕвгений СергеевичGubanovE. S.samara-urology@mail.ruФГБОУ ВО Самарский государственный медицинский университет Минздрава РоссииRussian FederationФГБУ «Объединенная больница с поликлиникой» Управления делами Президента Российской ФедерацииRussian Federation20161504202032731Copyright © Зимичев А.А., Корабельников А.С., Чернышев И.В., Низамова Р.С., Губанов Е.С., 20202020Зимичев А.А., Корабельников А.С., Чернышев И.В., Низамова Р.С., Губанов Е.С.Zimichev A.A., Korabelnikov A.S., Chernyshev I.V., Nizamova R.S., Gubanov E.S.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.spractice.ru/jour/article/view/25

Выполнено изучение возможностей выявления злокачественного образования простаты, прогнозирования заболевания, вопроса инцидентального рака предстательной железы. Проведен обзор отечественных и иностранных источников литературы, рассматривающих данные вопросы. Диагностика рака предстательной железы остается актуальным и дискутабельным вопросом онкоурологии. Инцидентальный рак простаты является распространенным заболеванием среди мужчин с ДГПЖ.

рак предстательной железыдиагностикабиопсияинцидентальный ракprostate cancerdiagnosisbiopsycancer intsidentalnyReferencesБорщ В.Ю., Варенпов Г.И., Захматов Ю.М. и соавт. Трансуретральная резекция при раке предстательной железы // Материалы Пленума Правления российского общества урологов.-М.-1999.-С.212-214.Борщ В.Ю., Варенпов Г.И., Захматов Ю.М. и соавт. Трансуретральная резекция при раке предстательной железы // Материалы Пленума Правления российского общества урологов.-М.-1999.-С.212-214.Бухаркин Б.В., Подрегуяьский К.Э. Рак предстательной железы// Клин. онкол. - 1999. - т.1, - №1. - С. 10-13.Бухаркин Б.В., Подрегуяьский К.Э. Рак предстательной железы// Клин. онкол. - 1999. - т.1, - №1. - С. 10-13.Вайнберг З.С. Неотложная урология.- М.1997.Вайнберг З.С. Неотложная урология.- М.1997.Пушкарь, Д.Ю. Простатспецифический антиген и биопсия предстательной железы / Д.Ю. Пушкарь. М.: Медпресс- информ, 2003. -159 с.Пушкарь, Д.Ю. Простатспецифический антиген и биопсия предстательной железы / Д.Ю. Пушкарь. М.: Медпресс- информ, 2003. -159 с.Злокачественные новообразования в России в 2014 году (заболеваемость и смертность)/ под. ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой//М.: РИИС ФИАН, 2016. - 4 с.Злокачественные новообразования в России в 2014 году (заболеваемость и смертность)/ под. ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой//М.: РИИС ФИАН, 2016. - 4 с.Медицинские Диссертации http://medical-diss.com/medicina/puti-povysheniya-effektivnosti-biopsii-predstatelnoy-zhelezy# ixzz2W64KMIhZ Guichard G., Larre’S., Gallina A. et al. Extended 21-sample needle biopsy protocol for diagnosis of prostate cancer in 1000 consecutive patients. Eur Urol 2007;52(2):430-5.Медицинские Диссертации http://medical-diss.com/medicina/puti-povysheniya-effektivnosti-biopsii-predstatelnoy-zhelezy# ixzz2W64KMIhZ Guichard G., Larre’S., Gallina A. et al. Extended 21-sample needle biopsy protocol for diagnosis of prostate cancer in 1000 consecutive patients. Eur Urol 2007;52(2):430-5.Урология/ под ред. Ю.Г. Аляева. - М.: Медицинское информационное агенство, 2005. - 640 с.Урология/ под ред. Ю.Г. Аляева. - М.: Медицинское информационное агенство, 2005. - 640 с.Argyropoulos A., Doumas K., Farmakis A. et al. Characteristics of patients with stage T1b incidental prostate cancer. Scand J UrolNephrol 2005;39(4):289-93.Argyropoulos A., Doumas K., Farmakis A. et al. Characteristics of patients with stage T1b incidental prostate cancer. Scand J UrolNephrol 2005;39(4):289-93.Antunes A.A., Freire Gde C., Aiello Filho D. et al. Analysis of the risk factors for incidental carcinoma of the prostate in patients with benign prostatic hyperplasia. Clinics 2006;61(6):545-50.Antunes A.A., Freire Gde C., Aiello Filho D. et al. Analysis of the risk factors for incidental carcinoma of the prostate in patients with benign prostatic hyperplasia. Clinics 2006;61(6):545-50.Andel G., VleemingR., Kurth K., de Reijke T.M. Incidental carcinoma of the prostate. Semin Surg Oncol 1995;11(1):36-45.Andel G., VleemingR., Kurth K., de Reijke T.M. Incidental carcinoma of the prostate. Semin Surg Oncol 1995;11(1):36-45.Bostwick D.G. The pathology of incidental carcinoma. Cancer Surv 1995;23: 7-18.Bostwick D.G. The pathology of incidental carcinoma. Cancer Surv 1995;23: 7-18.Capitanio U., Scattoni V., Freschi M. et al. Factors predicting pathological stage in patients submitted radical retropubic prostatectomy due to incidental (T1a-T1b) prostate cancer. Eur Urol 2007;(Suppl).Capitanio U., Scattoni V., Freschi M. et al. Factors predicting pathological stage in patients submitted radical retropubic prostatectomy due to incidental (T1a-T1b) prostate cancer. Eur Urol 2007;(Suppl).Herranz Amo F., Diez Cordero J.M., Verdu Tartajo F. et al. Incidental prostatic cancer Actas Urol Esp 1999;23(10): 848-52.Herranz Amo F., Diez Cordero J.M., Verdu Tartajo F. et al. Incidental prostatic cancer Actas Urol Esp 1999;23(10): 848-52.Leisinger H.J. Cancer of the prostate stage T1. Inci dental carcinoma. Review of the literature and an appraisal of the classification. Ann Urol (Paris) 1994;28(4): 229-34.Leisinger H.J. Cancer of the prostate stage T1. Inci dental carcinoma. Review of the literature and an appraisal of the classification. Ann Urol (Paris) 1994;28(4): 229-34.Masue N., Deguchi T., Nakano M. et al. Retrospective study of 101 cases with incidental prostate cancer stages T1a and T1b Six-year follow-up of untreated T1 carcinoma of prostate. Int J Urol 2005;12(12):1045-9.Masue N., Deguchi T., Nakano M. et al. Retrospective study of 101 cases with incidental prostate cancer stages T1a and T1b Six-year follow-up of untreated T1 carcinoma of prostate. Int J Urol 2005;12(12):1045-9.Marmiroli R, Antunes AA, et al. Standard surgical treatment for benign prostatic hyperplasia is safe for patients over 75 years: analysis of 100 cases from a high-volume urologic center. Clinics (Sao Paulo). 2012 Dec;67(12):1415-8.Marmiroli R, Antunes AA, et al. Standard surgical treatment for benign prostatic hyperplasia is safe for patients over 75 years: analysis of 100 cases from a high-volume urologic center. Clinics (Sao Paulo). 2012 Dec;67(12):1415-8.Meguro N., Maeda O., Saiki S. et al. Clinical significance of prostate specific antigen (PSA) and PSA density in the detection of T1a and T1b prostate cancer. Hinyokika Kiyo 1998;44(9):639-43.Meguro N., Maeda O., Saiki S. et al. Clinical significance of prostate specific antigen (PSA) and PSA density in the detection of T1a and T1b prostate cancer. Hinyokika Kiyo 1998;44(9):639-43.Paul R., Knebel C., van Randenborgh H. et al. Incidental carcinoma of the prostate: can we and should we recommend radical prostatectomy. Urologe A 2005;44(9):1052, 1054-8.Paul R., Knebel C., van Randenborgh H. et al. Incidental carcinoma of the prostate: can we and should we recommend radical prostatectomy. Urologe A 2005;44(9):1052, 1054-8.Robinson D., Aus G., Bak J. et al. Long-term follow-up of conservatively managed cidental carcinoma of the prostate: a multivariate analysis of prognostic factors. Scand J Urol Nephrol 2007;41(2):103-9.Robinson D., Aus G., Bak J. et al. Long-term follow-up of conservatively managed cidental carcinoma of the prostate: a multivariate analysis of prognostic factors. Scand J Urol Nephrol 2007;41(2):103-9.Stamley TA, Kabalin JN, McNeal JE, et al. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of prostate. II. Radical prostatectomy treats patients.// J Urol 1989;141:1076-83.Stamley TA, Kabalin JN, McNeal JE, et al. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of prostate. II. Radical prostatectomy treats patients.// J Urol 1989;141:1076-83.Tombal B., De Visccher L., Cosyns J.P. et al. Assessing the risk of unsuspected prostate cancer in patients with benign prostatic hyper-trophy: a 13-year retrospective study of the incidence and natural history of T1a-T1b prostate cancers. BJU Int 1999;84(9):1015-20.Tombal B., De Visccher L., Cosyns J.P. et al. Assessing the risk of unsuspected prostate cancer in patients with benign prostatic hyper-trophy: a 13-year retrospective study of the incidence and natural history of T1a-T1b prostate cancers. BJU Int 1999;84(9):1015-20.Vecchioli Scaldazza C. Incidental carcinoma of the prostate. Study of 683 patients operated upon for benign prostatic hypertrophy. Minerva Urol Nefrol 1992;44(2):109-12.Vecchioli Scaldazza C. Incidental carcinoma of the prostate. Study of 683 patients operated upon for benign prostatic hypertrophy. Minerva Urol Nefrol 1992;44(2):109-12.Voigt S, Htittig F et al. Risk factors for incidental prostate cancer-who should not undergo vaporization of the prostate for benignprostate hyperplasia? Prostate. 2011 Sep;71(12):1325-31. doi: 10.1002/pros.21349. Epub 2011 Feb 9.Voigt S, Htittig F et al. Risk factors for incidental prostate cancer-who should not undergo vaporization of the prostate for benignprostate hyperplasia? Prostate. 2011 Sep;71(12):1325-31. doi: 10.1002/pros.21349. Epub 2011 Feb 9.Yoo CZhao Z, Ma W, Zeng G, Qi D. PSCA mRNA expression in preoperatively negative prostate biopsies predicts incidental prostate 117 cancer in patients undergoing transurethral resection of the prostate for benign prostatic hyperplasia. Department of Urology, Minimally Invasive Surgery Center, The First Affiliated Hospital, Guangzhou Medical College, Guangzhou, Guangdong Province, China.Yoo CZhao Z, Ma W, Zeng G, Qi D. PSCA mRNA expression in preoperatively negative prostate biopsies predicts incidental prostate 117 cancer in patients undergoing transurethral resection of the prostate for benign prostatic hyperplasia. Department of Urology, Minimally Invasive Surgery Center, The First Affiliated Hospital, Guangzhou Medical College, Guangzhou, Guangdong Province, China.Yen-Chuan Ou, Jung-Ta Chen, Chen-Li Cheng, et al. Radical prostatectomy for prostate cancer patients with prostate-specific antigen >20 ng/ml. //Jpn J Clin Oncol 2003;33(11):574-579.Yen-Chuan Ou, Jung-Ta Chen, Chen-Li Cheng, et al. Radical prostatectomy for prostate cancer patients with prostate-specific antigen >20 ng/ml. //Jpn J Clin Oncol 2003;33(11):574-579.Zelefsky MJ, Leibel SA, Burman et al. Neoadjuvant hormonal therapy improves the therapeutic ratio in patients with bulky prostatic cancer treated with three-dimensional conformal radiation therapy. //Int J Radiat Oncol Biol Phys 1994;29:755-761.Zelefsky MJ, Leibel SA, Burman et al. Neoadjuvant hormonal therapy improves the therapeutic ratio in patients with bulky prostatic cancer treated with three-dimensional conformal radiation therapy. //Int J Radiat Oncol Biol Phys 1994;29:755-761.

The authors declare that there are no conflicts of interest present.